Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters








Publication year range
1.
Clin Exp Immunol ; 162(3): 415-24, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21029072

ABSTRACT

Intravenous immunoglobulin (IVIG) has been used widely to treat immune thrombocytopenic purpura (ITP), but the mechanisms of its action remain unclear. We investigated the affinity for Fcγ receptors (FcγRs) and the thrombocytopenia-ameliorating effect of S-sulfonated gammaglobulin (SGG) and S-alkylated gammaglobulin (AGG), in comparison with unmodified gammaglobulin (GG), in a mouse ITP model. Cleavage of immunoglobulin (Ig)G interchain disulfide bonds by either S-sulfonation or S-alkylation did not decrease the affinity for FcγRIIA (CD32A) and FcγRIIB (CD32B), but did decrease the affinity for FcγRIA (CD64A) and FcγRIIIA (CD16A), presumably because of changes in H-chain configuration. The interchain disulfide bond cleavage decreased the affinity much more for mouse FcγRIV than for mouse FcγRIIB. The ability of AGG to ameliorate ITP was greatly diminished, while SGG, whose disulfide bonds are reconstituted in vivo, was as effective as GG. These results suggest that the interchain disulfide bonds are important for therapeutic effect. It is also suggested that the interaction of IVIG with the inhibitory receptor FcγRIIB is insufficient for effective amelioration of ITP and that, at least in this model, direct binding of IVIG to FcγRIIIA is also required.


Subject(s)
Antibody Affinity/drug effects , Immunoglobulin G/administration & dosage , Immunoglobulins, Intravenous/administration & dosage , Immunotherapy , Purpura, Thrombocytopenic, Idiopathic/drug therapy , Alkylation , Animals , Disease Models, Animal , Disease Progression , Humans , Immunoglobulin G/adverse effects , Immunoglobulin G/chemistry , Immunoglobulins, Intravenous/adverse effects , Immunoglobulins, Intravenous/chemistry , Male , Mice , Mice, Inbred BALB C , Purpura, Thrombocytopenic, Idiopathic/immunology , Purpura, Thrombocytopenic, Idiopathic/physiopathology , Receptors, IgG/chemistry , Receptors, IgG/metabolism , Treatment Outcome
2.
Int J Androl ; 26(1): 52-6, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12534938

ABSTRACT

Succinyl CoA:3-oxo acid CoA transferase (SCOT/OXCT; EC 2.8.3.5) is a key mitochondrial enzyme in the metabolism of ketone bodies in various organs (but not in the liver). We identified a cDNA clone of the testicular germ cell-specific succinyl CoA transferase isozyme (SCOT-t). We then isolated a mouse orthologue of the SCOT/OXCT cDNA (SCOT-s) and determined the expression of the two types of SCOT in the testis. The mRNAs of scot-s and scot-t were expressed exclusively in testicular somatic cells (i.e. Leydig and Sertoli cells) and germ cells, respectively. SCOT enzymatic activities were assayed in Leydig cell (SCOT-s) and sperm (SCOT-t) fractions. The SCOT activity in sperm was 2.5-fold higher than that in Leydig cells. We conclude that germ cells and somatic cells differentially express the SCOT enzymes and that the SCOT activity of sperm caused exclusively by SCOT-t should play an important role in sperm activity.


Subject(s)
Coenzyme A-Transferases/genetics , Testis/cytology , Testis/enzymology , Animals , Gene Expression Regulation, Enzymologic , Leydig Cells/enzymology , Male , Mice , Mitochondria/enzymology , Molecular Sequence Data , Sertoli Cells/enzymology , Spermatocytes/enzymology
3.
FEBS Lett ; 505(2): 223-8, 2001 Sep 14.
Article in English | MEDLINE | ID: mdl-11566180

ABSTRACT

Suppressors of cytokine signaling (SOCS) proteins possess common structures, a SOCS box at the C-terminus and a SH2 domain at their center. These suppressors are inducible in response to cytokines and act as negative regulators of cytokine signaling. The ASB proteins also contain the SOCS box and the ankyrin repeat sequence at the N-terminus, but do not have the SH2 domain. Although Socs genes are directly induced by several cytokines, no Asb gene inducers have been identified. In this study, we screened the specific genes expressed in the course of differentiation of HL-60 cells, and demonstrated that ASB-2, one of the ASB proteins, was rapidly induced by all-trans retinoic acid (ATRA). Typical retinoid receptors (RARs) or retinoid X receptors (RXRs) binding element (RARE/RXRE) were presented in the promoter of the Asb-2 gene. We showed that RARalpha, one of the RARs, binds to the RARE/RXRE in the Asb-2 promoter. In addition, we demonstrated by luciferase reporter assay that this element was a functional RARE/RXRE. These findings indicate that ASB-2 is directly induced by ATRA and may act as a significant regulator, underlying such physiological processes as cell differentiation.


Subject(s)
Adaptor Proteins, Signal Transducing , Carrier Proteins/biosynthesis , Carrier Proteins/chemistry , Tretinoin/pharmacology , Amino Acid Sequence , Animals , Base Sequence , Blotting, Northern , Blotting, Western , Cell Differentiation , Cell Division , Cell Line , Cytokines/metabolism , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , HL-60 Cells , Humans , Luciferases/metabolism , Mice , Molecular Sequence Data , Promoter Regions, Genetic , Protein Structure, Tertiary , RNA, Messenger/metabolism , Receptors, Retinoic Acid/metabolism , Signal Transduction , Suppressor of Cytokine Signaling Proteins , Time Factors , Transfection
4.
Mol Hum Reprod ; 7(3): 211-8, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11228240

ABSTRACT

We report here the molecular cloning and characterization of human haspin cDNA and its genomic DNA construct. The haspin protein is a unique protein kinase, first isolated from mouse testis. Specifically expressed in mouse testicular germ cells, haspin is suggested to play a role in cell cycle arrest in haploid spermatids. Detection of human haspin by Northern blot analysis showed that the major transcript was 2.8 kilobases long and detected exclusively in the testis. The entire coding region of the human cDNA showed 68% identity with mouse haspin. The predicted amino acid sequence showed strong conservation of the kinase catalytic domain, leucine zipper, potential phosphorylation sites, and MEF2B homologous region, but a relatively unique N:-terminal region. Human haspin protein was also demonstrated to have protein kinase activity. The human haspin gene was mapped to chromosome 17p13 by computer database cloning of human genomic DNA. Furthermore, the genomic structure of human haspin was proven to be intronless and the whole transcription unit was found to be located in an intron of the integrin alphaE2 gene.


Subject(s)
Chromosomes, Human, Pair 17 , Leucine Zippers , Protein Serine-Threonine Kinases/genetics , Amino Acid Sequence , Animals , Base Sequence , Cell Line , Chromosome Mapping , Cloning, Molecular , DNA, Complementary , Gene Expression , Humans , Intracellular Signaling Peptides and Proteins , Mice , Molecular Sequence Data , Protein Serine-Threonine Kinases/biosynthesis , Protein Serine-Threonine Kinases/metabolism , RNA, Messenger , Sequence Homology, Amino Acid , Sequence Homology, Nucleic Acid
5.
Biol Pharm Bull ; 23(2): 145-8, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10706375

ABSTRACT

Two metallothionein cDNAs (MT-A and MT-B) in the fresh-water fish crucian carp (Carassius cuvieri Temminck et Schlegel) were cloned. Sequence analysis of both cDNAs gave the structure of a coding region corresponding to 60 amino acid residues. The homology of their deduced amino acid sequences was completely conserved at the positions of the cysteine residue, but a significant difference existed in the size of their 3'-untranslated regions (130 base pairs for MT-A and 280 base pairs for MT-B). Direct amino acid sequencing of the MT-II isoform purified by HPLC was accomplished for up to 30 residues and its sequence was identical to that deduced from MT-B cDNA. This is the first case in vertebrates that N-terminal methionine in crucian carp MT-II was not blocked. By northern blot analysis, basal and cadmium chloride- or dexamethasone-induced MT-B (MT-II) mRNAs were detected time dependently after treatment. On the other hand, the expression of MT-A mRNA was extremely low. These results indicate that the MT isoform II in crucian carp is coded by the MT-B gene, and that the MT-B-dominant expression of mRNA in crucian carp may be due to the difference in the 3'-untranslated regions of MT mRNAs.


Subject(s)
Carps/metabolism , DNA, Complementary/biosynthesis , Metallothionein/biosynthesis , Amino Acid Sequence , Animals , Base Sequence , Blotting, Northern , Cloning, Molecular , DNA, Complementary/genetics , Fishes , Isoenzymes/biosynthesis , Isoenzymes/genetics , Liver/enzymology , Metallothionein/genetics , Metallothionein/isolation & purification , Mice , Molecular Sequence Data , Rats , Species Specificity
6.
Res Commun Mol Pathol Pharmacol ; 108(5-6): 381-91, 2000.
Article in English | MEDLINE | ID: mdl-11958291

ABSTRACT

We investigated the induction of differentiation in human promyelocytic HL-60 leukemia cells by a relatively low concentration of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). The cells were markedly induced to differentiate by combined treatment with reduced concentrations of dimethyl sulfoxide (DMSO) and 1,25(OH)2D3, neither of which alone had much of an effect on differentiation. At 48 hr post-treatment, a greater proportion of DMSO- and DMSO/1,25(OH)2D3-treated, but not 1,25(OH)2D3-treated, cells were in G0/G1 than untreated cells. Our study indicates that the synergistic effect of DMSO and 1,25(OH)2D3 on the induction of differentiation in HL-60 cells requires DMSO-induced G0/G1 arrest.


Subject(s)
Calcitriol/pharmacology , Dimethyl Sulfoxide/pharmacology , Free Radical Scavengers/pharmacology , Leukocytes/drug effects , Cell Cycle/drug effects , Cell Differentiation/drug effects , Dithizone/pharmacology , HL-60 Cells , Humans , Indicators and Reagents , Leukocytes/ultrastructure , Nitroblue Tetrazolium
7.
Biochem Biophys Res Commun ; 270(2): 458-61, 2000 Apr 13.
Article in English | MEDLINE | ID: mdl-10753647

ABSTRACT

Metallothionein (MT) can modulate transcriptional activity in vitro. We examined whether the absence of MT affects gene expression in vivo. We compared the hepatic RNA profiles of wild-type and MT-null neonatal mice using improved differential display. The hepatic MT level was maximal during neonatal development. We identified five cDNA fragments that were expressed in MT-null mice at different levels from those in wild-type mice. Two were fragments of MT-I and mutant MT-I cDNA. The sequences of the other cDNA fragments were identical to those of contrapsin, transketolase, and vanin-3. The latter two were up-regulated, whereas contrapsin was down-regulated in neonatal MT-null mice. These mRNA levels were remarkably different between the two strains of neonatal mice. Further characterization of the regulated mRNA identified here will determine whether or not they are primary or secondary effects of an MT deficiency.


Subject(s)
Gene Expression Regulation, Developmental , Hydrolases , Metallothionein/genetics , Serpins , Amidohydrolases , Animals , Base Sequence , Blotting, Northern , Cell Adhesion Molecules/genetics , DNA Primers , DNA, Complementary , GPI-Linked Proteins , Mice , Mice, Knockout , RNA, Messenger/genetics , Transketolase/genetics , Trypsin Inhibitors/genetics
8.
Biochem Biophys Res Commun ; 262(2): 365-7, 1999 Aug 27.
Article in English | MEDLINE | ID: mdl-10462481

ABSTRACT

We propose a novel alternative approach, an advanced method for recently developed strategies, for identifying differentially expressed genes. Firstly, double-stranded cDNAs were digested using Sau3AI and the 3'-end restriction fragments of the cDNA were ligated to a double-stranded adapter. Next, the restriction fragments were directly amplified using several combinations of adapter-specific primers and FITC-labeled oligo dT primers. The selected cDNA fragments were displayed on a polyacrylamide gel. Neither nested PCR nor purification of 3'-end fragments are necessary. We examined the validity of this approach by evaluating gene expression changes during granulocytic differentiation of HL-60 cells. This method can theoretically detect almost all gene expression changes more rapidly and through simpler manipulations than by any other approach.


Subject(s)
Cloning, Molecular/methods , Gene Expression , Granulocytes/cytology , Cell Differentiation , DNA Primers , DNA, Complementary/biosynthesis , HL-60 Cells , Humans , Polymerase Chain Reaction , Transcription, Genetic
9.
Cell Prolif ; 32(1): 63-73, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10371304

ABSTRACT

Hinokitiol, a potent iron chelator, has been reported to induce differentiation in teratocarcinoma F9 cells with a reduction of viable cells. In this study, we examined the steps leading to eventual cell death by hinokitiol during differentiation. Hinokitiol induced DNA fragmentation of F9 cells in a concentration- and time-dependent manner. This effect was also observed in a cell-free system using the nuclei from intact cells and the cytosols from hinokitiol-treated cells. In contrast, hinokitiol methyl ether and hinokitiol-Fe (III) complex, which are deficient in iron-chelating activity, showed no DNA fragmentation activity in both cell culture and cell-free systems. These results suggest that iron deprivation by hinokitiol may be involved in the induction of apoptosis of F9 cells. Caspase-3, one of the key enzymes in the apoptotic cascade, was specifically activated by hinokitiol treatment, but not by the other two derivatives. In addition, its specific inhibitor, benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone, strongly blocked hinokitiol-induced DNA fragmentation. These results indicate that iron deprivation by hinokitiol can induce apoptosis of F9 cells through the activation of caspase-3.


Subject(s)
Apoptosis/drug effects , Caspases/metabolism , Iron Chelating Agents/pharmacology , Monoterpenes , Neoplastic Stem Cells/drug effects , Teratocarcinoma , Tropolone/analogs & derivatives , Amino Acid Chloromethyl Ketones/pharmacology , Aniline Compounds/pharmacology , Caspase 3 , Cell-Free System , Cysteine Proteinase Inhibitors/pharmacology , DNA Fragmentation , Embryonal Carcinoma Stem Cells , Enzyme Activation/drug effects , Enzyme Activation/physiology , Neoplastic Stem Cells/cytology , Neoplastic Stem Cells/enzymology , Oligopeptides/pharmacology , Tropolone/pharmacology
10.
Cell Biol Int ; 23(8): 541-50, 1999.
Article in English | MEDLINE | ID: mdl-10704238

ABSTRACT

We have previously demonstrated that three potent iron chelators, hinokitiol, dithizone and deferoxamine, induce differentiation of F9 embryonal carcinoma cells, as do other well-known morphogens such as retinoic acid (RA) and sodium butyrate (NaB). In this study, we compared the patterns of cell proliferation, cell death and cell cycle arrest during the process of differentiation induced by these five agents. When F9 cells were cultured with the agents at their individual differentiation-inducing concentrations, cell proliferation was rapidly inhibited by treatment with the iron chelators and NaB. In contrast, RA did not influence the rate of increase of cell number at the concentration of 1 microm. The three chelators also caused a marked reduction in cell viability, and the treated cells exhibited internucleosomal DNA fragmentation, whereas cells treated with NaB showed no apoptotic characteristics. RA induced apoptosis weakly at 1 microm and strongly at higher concentrations. In addition, all the iron chelators hindered cell cycle progression, resulting in an arrest at the G1-S interface or S phase. The phenomena observed in chelator-treated cells were considerably different from those in RA- or NaB-treated cells. It is concluded that the three iron chelators cause both severe apoptotic cell death and cell cycle arrest of proliferating F9 cells via cellular iron deprivation, and that this apoptotic change may be independent of the process of differentiation.


Subject(s)
Apoptosis/drug effects , Iron Chelating Agents/pharmacology , Monoterpenes , Neoplastic Stem Cells/cytology , Tropolone/analogs & derivatives , Animals , Antineoplastic Agents/pharmacology , Butyrates/pharmacology , Cell Differentiation/drug effects , Chelating Agents/pharmacology , DNA Fragmentation/drug effects , Deferoxamine/pharmacology , Dithizone/pharmacology , Dose-Response Relationship, Drug , Embryonal Carcinoma Stem Cells , Image Cytometry , Tretinoin/pharmacology , Tropolone/pharmacology
11.
Leuk Res ; 22(5): 405-12, 1998 May.
Article in English | MEDLINE | ID: mdl-9652726

ABSTRACT

We investigated the effect of diphenylthiocarbazone (dithizone) and its structurally related compounds on the differentiation and apoptosis of two human myeloid leukemia cell lines. Dithizone caused a time- and concentration-dependent induction of differentiation in both the promyelocytic leukemia cell line HL-60 cells and the myeloblastic leukemia cell line ML-1 cells, as measured by nitroblue tetrazolium (NBT) reducing activity. Morphological changes and esterase activities confirmed that this differentiation took place. The induction of differentiation required the addition of dithizone to the culture medium for at least 12 h. The differentiation inducing activity was inhibited by the preincubation of dithizone with various metal ions such as Pb2+, Zn2+, Cu2+ and Mn2+ ions, but not with Fe3+ and Mg2+ ions. In addition, the DNA extracted from dithizone-treated HL-60 cells showed a typical ladder pattern characteristic of apoptosis in agarose gel electrophoresis. A quantitative analysis of DNA fragmentation revealed that this apoptosis was concentration- and time-dependent in both the HL-60 and ML-1 cells. Dithizone-induced apoptosis was also inhibited by preincubation with Mn2+ ions, but not with Mg2+ ions. These results indicate that dithizone induces both differentiation and apoptosis in HL-60 and ML-1 cells through a unique mechanism including metal chelation.


Subject(s)
Apoptosis/drug effects , Dithizone/pharmacology , Leukemia, Myeloid/pathology , Acute Disease , Cell Transformation, Neoplastic/chemically induced , Cell Transformation, Neoplastic/drug effects , DNA Fragmentation/drug effects , HL-60 Cells/cytology , HL-60 Cells/drug effects , Humans , Ions , Leukemia, Myeloid/genetics , Leukemia, Myeloid, Acute/genetics , Leukemia, Myeloid, Acute/pathology , Magnesium/pharmacology , Metals/antagonists & inhibitors , Time Factors , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL